Cookie Img
Home » Products » Cancer Injections & Vial » Transtuzumab

Transtuzumab

Transtuzumab
Transtuzumab
Product Code : 98
Product Description

Transtuzumab:-

Transtuzumab is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.
Trastuzumab is approved to be used alone or with other drugs to treat:

 Adenocarcinoma of the stomach or gastroesophageal junction. It is used for HER2 positive (HER2+) disease that has metastasized (spread to other parts of the body) in patients who have not already been treated for metastatic cancer.

    Breast cancer that is HER2+. It is used in patients whose disease has not gotten better with other chemotherapy.
Trastuzumab usually is administered intravenously with an initial dose of 4 mg per kilogram of body weight followed by a weekly dose of 2 mg per kilogram of body weight. 


3S CORPORATION

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



"We mainly export our products to the foreign countries."
Back to top
3S CORPORATION All Rights Reserved.